Industry Developments
United States
US-based biotechnology company Momenta Pharmaceuticals has received US Food and Drug Adminitsration (FDA) marketing approval for its generic version of Sanofi-Aventis's antithrombotic...
2010-07-28Sales recorded by the world's 10th largest pharmaceutical company, Eli Lilly, increased from US$5.3bn in Q209 to US$5.7bn in Q210, a rise of 8.6%. Net profits grew by 16.4% and earnings...
2010-07-26United States
BMI view: US-based Abbott Laboratories will outperform its peers over the medium term. The diversified biopharmaceutical company has a growing presence in non-traditional markets, thereby...
2010-07-22United States
BMI Core View: The development and marketing of therapeutics in combination with diagnostics will become more common. It is increasingly clear that the 'one size fits all' approach...
2010-07-22The attractiveness of the Americas to multinational pharmaceutical companies has increased, according to BMI's Pharmaceutical & Healthcare Business Environment Ratings (BERs) for...
2010-07-21United States
The US Food and Drug Administration (FDA)'s Advisory Committee On Endocrinology And Metabolic Drugs has determined that Vivus's weight loss drug Qnexa should not be granted marketing...
2010-07-20Brazil
General Electric (GE) is to invest US$150mn over the next 18 months on a research and development (R&D) centre in Brazil. The US multinational is currently negotiating with several...
2010-07-19United States
The US Food and Drug Administration (FDA) has decided to allow continued availability of Avandia (rosiglitazone), one of GlaxoSmithKline (GSK)'s best selling drugs in the US. The safety...
2010-07-16
